Profilo
Kathleen Wilkinson is currently the Director at North Texas Commission and the Chief People Officer at Rapport Therapeutics, Inc. Formerly, Ms. Wilkinson was the Chief People Officer at 2seventy Bio, Inc. from 2022 to 2024, the Chief People Officer at bluebird bio, Inc. in 2021, and the Operations Director at Adnexus.
Ms. Wilkinson completed undergraduate studies at Harvard University.
Posizioni attive di Kathleen Wilkinson
| Società | Posizione | Inizio |
|---|---|---|
| RAPPORT THERAPEUTICS, INC. | Ufficiale delle Risorse Umane | 01/02/2024 |
North Texas Commission
North Texas Commission Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit membership-supported organization | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Kathleen Wilkinson
| Società | Posizione | Fine |
|---|---|---|
| 2SEVENTY BIO, INC. | Ufficiale delle Risorse Umane | 01/02/2024 |
| GENETIX BIOTHERAPEUTICS, INC. | Ufficiale delle Risorse Umane | 01/12/2021 |
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Develops medicines which includes protein antagonists | Direttore operativo | - |
Formazione di Kathleen Wilkinson
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
bluebird bio, Inc.
bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Develops medicines which includes protein antagonists | Health Technology |
North Texas Commission
North Texas Commission Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit membership-supported organization | Commercial Services |
2seventy Bio, Inc.
2seventy Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for the treatment of cancer and genetic diseases | Health Technology |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder | Health Technology |
















